Rajiv S. Dahiya, M.D.

Dr. Rajiv “Raj” Dahiya is a board-certified radiation oncologist with extensive experience in cancers of the prostate, head & neck, lung, breast, GI tract, skin as well as brain tumors. With over 18 years of clinical experience including Intensity Modulated Radiation Therapy (IMRT) with Varian True Beam Rapid Arc system, stereotactic radiosurgery (SRS) with Cyberknife and GammaKnife units.

Graduated from 1st 6-year combined BA/MD program in US (U of Missouri – Kansas City School of Medicine) and attended Harvard Business School/YPO President’s Program 2014. Completed first residency in Internal Medicine at Baylor University Medical Center followed by second residency at the University of Texas Health Science Center at San Antonio where he served as Chief Resident and worked with IMRT technology in its developmental stage.

He has authored numerous publications and is the co-author of Understanding Microinflammation: The Common Link Between Aging, Cancer and Coronary Disease. Selected to SuperDoctors Texas 2011-2017.

Dr. Dahiya has worked with Santé Nou Health where his roles included chief healthcare architect of a complex Population Health Program for Haiti working closely in conjunction with a number of multi-nationals and government entities. The program seeks to deliver prompt on demand healthcare throughout the country and region and aims to improve the United Nations Development Program Human Development Index (UNDP HDI).

• University of Missouri-Kansas City School of Medicine
  • 6-year combined BA/MD medical school from high school
  • Jul 1988 – May 1994

• Baylor Medical Center
  • Internal Medicine – Internship (Jul 1994 – Jun 1995)
  • Internal Medicine – Residency (Jul 1995 – Jun 1997)
  • Board Certification (1997)

• University of Texas Health Science Center at San Antonio
  • Radiation Oncology – Residency (Jul 1998 – Jun 2002)
  • Chief Resident Radiation Oncology (2001-2002)
  • Board Certification 2003 & recertified 2015 (valid until 2025)

• Harvard Business School/YPO President’s Week 1 Program Jan 2014

• University of Missouri Curators Academic Scholar
• Missouri State Medical Brightflight Scholar
• Missouri Westlake Foundation Academic Scholar
• Flarsheim Merit Scholar
• Mid-America Heart Institute Student Cardiology
• Research fellow 1993 St. Luke’s hospital in Kansas City, Missouri

• Young Presidents Organization (YPO) 2011-2017
• American Society for Therapeutic Radiation Oncology (ASTRO)
• American College of Radiation Oncology (ACRO)
• American College of Radiation (ACR)
• Radiological Society of North America (RSNA)
• American Medical Association (AMA)
• American Cancer Society (ACS)
• American Association of Physicians of Indian Origin (AAPI)
• Texas Medical Association (TMA)
• Florida Medical Association (FMA)
• Dallas County Medical Society

• Neurophysiology research assistant 1992. Neuropeptide-Y levels in anterior and posterior pituitary levels of rat species. Keith Gary, Ph.D., Bibie Chronwall, Ph.D.
• Concomitant weekly cisplatin and thoracic radiotherapy for pancoast tumors of the lung. Pilot Experience of the San Antonio Cancer Institute. American of Journal of Clinical Oncology 2000. Barnes JB, Dahiya RS, Johnson SB, Temes RT, Thomas CR Jr, Herman TS.
• Influence of radiotherapy on 6 sulphatoxmelatonin level in the urine of Brain cancer patients. Neuro Endocrinology Letters, volume 21 (3), June, 2000 Vijayalaxmi, Selva M, Dahiya, RS, Reiter RJ, Meitz ML, Prihoda TJ, Barnes J, Leal BZ, Herman TS.
• Phase I/II study of weekly Paclitaxel, daily Cisplatin and concurrent Radiation with or without Amifostine in unresectable head and neck cancer. Accepted for publication at the 1999 Radiological Society of North American (RSNA) Meeting. Zellers RC, Diab S, Otto RA, Tan W, Tin-UC, Villalona-Caler M, Barnes J, Dahiya,RS, Hardy JB, Bready BB, HERMAN TS.
• Phase I study of weekly Paclitaxel, in combination with daily Cisplatin and Radiation in locally advance head and neck, locally advanced non-small Cell lung carcinoma (NSCL), and esophageal carcinoma. Presented at the American Society of Clinical Oncology (ASCO) meeting on May 1998. Tan W, Tin-UC, Zellers RC, Herman TS, Villalona-Calero M, Valley AW, Kalidas M, Ochoa L, Drengler R, Khoury P, Alder L, Barnes J, Dahiya,RS, Hardy, J, Bready, BB, Weiss GR, Otto RA, Rowinsky E, Diab SG.
• Comparison of Morbidity and Mortality Rates with Coronary Artery Bypass Graft Surgery vs. Percutaneous Transluminal Coronary Angioplasty after CABG in Elderlay Patients with Comorbid Illness. Journal of the American College of Cardiology, 1996. O’Keefe J, Dahiya RS, et. al.
• CT Guided Prostate Brachytherapy Using Pinpoint Stereotactic Arm Blough, M, Hevezi, J, Eng, TY, Dahiya, RS, Chopra, S. Sumitted Apr 2001 to the 22nd American Brachtherapy Society Meeting. UT Health Science Center at San Antonio, TX, USA. Dept of Radiation Oncology.
• Anistropy of Cesium-137 Sources Measured with a Pure Germanium Detector. Barnes, JB, Dahiya, RS, Esquivel C, Wiecokowska RD, Waggener, R, Herman, TS Thomas, CR. Submitted Apr 2001 to American Society for Therapeutic Radiation Oncology (ASTRO). UT Health Science Center at San Antonio, TX, USA. Dept of Radiation Oncology.
• Oropharyngeal candidates caused by non-albicans yeast in patients receiving external beam radiotherapy (EBRT) for head and neck cancer. Caceres, M, Dahiya, RS, Eng, TY, Redding, SW, Thomas, CR. Submitted Mar 2001 to American Society of Clinical Oncology.
• Phase II Translational Pilot Study of melatonin cytoprotection from toxicity induced from concomitant chemoradiation for non-small cell lung cancer (NSCLC). Vijayalaxmi, Dahiya RS, Thomas, CR, Eng, TY, Herman, TS.
• Understanding Microinflammation: The Common Link Between Aging, Cancer and Coronary Disease. Dr. Kenneth Johnson & Dr. Rajiv Dahiya. June 23, 2014.
• Dr. Rajiv Dahiya practices at Urology Clinics of North Texas (UCNT) location at the Trophy Club Radiation Center and serves the communities of Trophy Club, Westlake, Southlake, Roanoke, Colleyville, Flower Mound, Keller, Grapevine, North Richland Hills, Watauga, Hurst, Euless, Bedford, Denton, Decatur, Lewisville and more.

Cancer of the Genitourinary Tract including:

• Prostate Cancer – Early and locally advanced
• Bladder Cancer
• Kidney Cancer
• Metastatic disease

• Photon based radiation therapy
• Intensity Modulated Radiotherapy (IMRT)
• Image Guided Radiation Therapy (IGRT)
• On board imaging (OBI)
• Rapid Arc Therapy
• 3-D Conformal Radiotherapy